SCHEMBL1103018

SCHEMBL1103018

c1ccc2c(c1)N(c1c3ccccc3c(N3c4ccccc4[Si]4(CCCC4)c4ccccc43)c3ncccc13)c1ccccc1[Si]21CCCC1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.34
L3MBTL1 Q9Y468 8/20 0.34
MAPT P10636 7/20 0.34
LMNA P02545 5/20 0.34
HTT P42858 5/20 0.34
ALDH1A1 P00352 5/20 0.34
TP53 P04637 4/20 0.34
MAPK1 P28482 4/20 0.34
ALOX12 P18054 3/20 0.34
USP2 O75604 2/20 0.34
POLB P06746 2/20 0.34
KMT2A Q03164 2/20 0.34
HSD17B10 Q99714 1/20 0.34
PAX8 Q06710 1/20 0.34
NFKB1 P19838 3/20 0.33
NFKB2 Q00653 3/20 0.33
RELA Q04206 3/20 0.33
ALOX15 P16050 2/20 0.33
GAA P10253 3/20 0.32
BRD4 O60885 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1102902 0.83 L3MBTL1 (0.36) KDM4EL3MBTL1MAPTLMNAHTT
SCHEMBL1102741 0.79 MAOA (0.32) KDM4EALDH1A1SMN1; SMN2HPGD
SCHEMBL1102977 0.75 HTT (0.38) KDM4EL3MBTL1MAPTLMNAHTT
SCHEMBL1103025 0.75 KDM4E (0.37) KDM4EL3MBTL1MAPTLMNAHTT
SCHEMBL1102797 0.75 HTT (0.38) KDM4EL3MBTL1MAPTLMNAHTT
SCHEMBL1102903 0.75 KDM4E (0.43) KDM4EL3MBTL1MAPTLMNAHTT
SCHEMBL1102901 0.74 HTT (0.38) KDM4EL3MBTL1MAPTLMNAHTT
SCHEMBL1102983 0.74 KMT2A (0.40) L3MBTL1LMNAHTTPOLBKMT2A
SCHEMBL1103092 0.72 PAX8 (0.32) KDM4EL3MBTL1MAPTLMNAHTT
SCHEMBL1102807 0.71 HSP90AA1 (0.36) KDM4EL3MBTL1MAPTLMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8153279-B2 Organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2012-04-10 US disclosed
US-8153279-B2 Organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2012-04-10 US disclosed
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 US disclosed
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same ORMDL3, OCIAD2, OCIAD1 KDM4E 3367/4885L3MBTL1 1629/4885MAPT 3162/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.